AKT1 and esophageal squamous cell carcinoma: Consistent with the published data on the relationship between SDCBP and EGFR, in our previous study, SDCBP was abundantly expressed in ESCC and accelerated the formation of ESCC tumors by interacting with EGFR and initiating the EGFR-PI3K-Akt signaling pathway26.